Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma

被引：0
|
作者：
Moldvay, J. [1 ]
Teglasi, V. [2 ]
Pipek, O. [3 ]
Rojko, L. [4 ]
Glasz, T. [2 ]
Vagvolgyi, A. [4 ]
Kovalszky, I. [2 ]
Gyulai, M. [5 ]
Lohinai, Z. [4 ]
Raso, E. [2 ]
Timar, J. [2 ]
Dome, B. [4 ]
Szallasi, Z. [2 ]
Reiniger, L. [2 ]
机构：
[1] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary
[2] Semmelweis Univ, Budapest, Hungary
[3] Elte, Budapest, Hungary
[4] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[5] Cty Hosp Pulmonol, Torokbalint, Hungary
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
PD-L1; lepidic growth pattern; tumor necrosis;
D O I：
10.1016/j.jtho.2019.08.1053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.09-24
引用
收藏
页码：S505 / S505
页数：1
相关论文
共 50 条
  • [21] The Intrinsic PD-L1 Promotes Cellular Invasiveness Via their PD-1 Receptor in Lung Adenocarcinoma Cells
    Su, W.
    Wu, H.
    Yang, S.
    Huang, J.
    Yan, J.
    Kao, W.
    Chang, L.
    Su, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S374 - S375
  • [22] Clinical Significance of PD-L1 Status and the Expression of PD-1 in Tumor-Infiltrating Lymphocytes (TILs) in Lung Cancer
    Ortiz-Villalon, Cristian
    Karagkounis, Georgios
    Kis, Lorand
    Lewensohn, Rolf
    Rassidakis, Georgios
    Tendler, Salomon
    De Petris, Luigi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1514 - S1514
  • [23] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [24] Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
    Galland, Loick
    Le Page, Anne Laure
    Lecuelle, Julie
    Bibeau, Frederic
    Oulkhouir, Youssef
    Derangere, Valentin
    Truntzer, Caroline
    Ghiringhelli, Francois
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [25] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Rosemarie Tremblay-LeMay
    Nasrin Rastgoo
    Hong Chang
    Journal of Hematology & Oncology, 11
  • [26] PD-L1 Expression in Ampullary Adenocarcinoma
    Siddiqui, Saima Haleem
    Kumari, Niraj
    Mishra, Shravan
    Radha, Paturu
    Mohindra, Samir
    Singh, Rajneesh K.
    Krishnani, Narendra
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (02) : 263 - 272
  • [27] PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
    Yang, Shijie
    Zhang, Qiuyang
    Liu, Sen
    Wang, Alun R.
    You, Zongbing
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2016, 4 (01): : 1 - 8
  • [28] Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti PD-1/PD-L1 therapy
    Roberts, Jordan A.
    Gonzalez, Raul S.
    Das, Satya
    Berlin, Jordan
    Shi, Chanjuan
    HUMAN PATHOLOGY, 2017, 70 : 49 - 54
  • [29] PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
    Ma, Ke
    Wei, Xin
    Dong, Danfeng
    Wu, Yinying
    Geng, Qianqian
    Li, Enxiao
    ONCOLOGY LETTERS, 2017, 14 (01) : 250 - 256
  • [30] PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?
    Chen, Sonja
    Guenther, Lillian M.
    Aronhalt, Amanda
    Cardillo, Lacey
    Janeway, Katherine A.
    Church, Alanna J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (08) : 482 - 487
12345